The estimated Net Worth of Alfred F. Ingulli is at least $452 Tisíc dollars as of 1 May 2018. Mr. Ingulli owns over 10,413 units of American Vanguard stock worth over $63,213 and over the last 14 years he sold AVD stock worth over $220,443. In addition, he makes $168,500 as Independent Director at American Vanguard.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Ingulli AVD stock SEC Form 4 insiders trading
Alfred has made over 1 trades of the American Vanguard stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 10,413 units of AVD stock worth $220,443 on 1 May 2018.
The largest trade he's ever made was selling 10,413 units of American Vanguard stock on 1 May 2018 worth over $220,443. On average, Alfred trades about 694 units every 0 days since 2010. As of 1 May 2018 he still owns at least 10,414 units of American Vanguard stock.
You can see the complete history of Mr. Ingulli stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Alfred Ingulli biography
Alfred F. Ingulli serves as Independent Director of the Company. Mr. Ingulli served as Executive Vice President of Crompton Corporation (later Chemtura Corporation), a $3 billion specialty chemical company from 1989 through 2004, in which capacity he was responsible for the company’s global agricultural chemical business. In addition, from 2002 to 2004 he also served as a member of Crompton Corporation’s executive committee. From 2005 to 2014, Mr. Ingulli served on the board of directors of PBI/Gordon, Inc., a marketer of specialty chemicals in turf and ornamental, lawn and garden and animal health markets, and served as a member of the compensation and audit committees of that board. Further, from 1996 to 2004, he served on the board of directors of Gustafson LLC, a manufacturer of seed treatment products and application equipment, and was chairman of that board from 2002 to 2004. From 1990 to 2004, Mr. Ingulli also served as a board member and, from 1998 to 2000, as Chairman, of CropLife America, a nationwide not-for-profit trade organization representing member companies that produce, sell, and distribute most of the active compounds used in crop protection
What is the salary of Alfred Ingulli?
As the Independent Director of American Vanguard, the total compensation of Alfred Ingulli at American Vanguard is $168,500. There are 14 executives at American Vanguard getting paid more, with Eric Wintemute having the highest compensation of $1,954,940.
How old is Alfred Ingulli?
Alfred Ingulli is 78, he's been the Independent Director of American Vanguard since 2010. There are no older and 21 younger executives at American Vanguard.
What's Alfred Ingulli's mailing address?
Alfred's mailing address filed with the SEC is 4695 MACARTHUR COURT, STE 1200, , NEWPORT BEACH, CA, 92660.
Insiders trading at American Vanguard
Over the last 21 years, insiders at American Vanguard have traded over $50,676,664 worth of American Vanguard stock and bought 629,726 units worth $5,875,021 . The most active insiders traders include Glenn A Wintemute, Eric G Wintemute a Herbert A Kraft. On average, American Vanguard executives and independent directors trade stock every 29 days with the average trade being worth of $98,474. The most recent stock trade was executed by Keith M Cruiser Capital Adv... on 30 August 2024, trading 136,492 units of AVD stock currently worth $790,289.
What does American Vanguard do?
american vanguard corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the united states and internationally. the company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. it also markets and distributes end-use chemical and biological products for crop applications; distributes chemicals for greenhouse and nursery production markets; and offers formulations, such as pcnb, chlorothalonil, and propiconazole under the ffii and ffiii names. the company distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. american vanguard corporation was founded in 196
What does American Vanguard's logo look like?
Complete history of Mr. Ingulli stock trades at American Vanguard
American Vanguard executives and stock owners
American Vanguard executives and other stock owners filed with the SEC include:
-
Eric Wintemute,
Chairman of the Board, Chief Executive Officer -
Eric G. Wintemute,
Chairman & CEO -
David Johnson,
Chief Financial Officer, Vice President, Treasurer -
Ulrich Trogele,
Executive Vice President, Chief Operating Officer of AMVAC Chemical Corporation -
Timothy Donnelly,
Chief Administrative Officer, General Counsel, Secretary -
Dr. Ulrich G. Trogele Ph.D.,
COO & Exec. VP -
Peter Eilers,
Managing Director, Amvac Netherlands BV -
Timothy J. Donnelly Esq.,
Gen. Counsel, Chief Admin. Officer & Sec. -
David T. Johnson,
VP, CFO & Treasurer -
Anthony Hendrix,
Senior Vice President - Crop Sales for U.S. & Canada -
Timothy J. Donnelly,
Gen. Counsel, Chief Admin. Officer & Sec. -
Peter E. Eilers,
Managing Director of AMVAC Netherlands BV -
Anthony Hendrix,
Sr. VP of Crop Sales for U.S. & Canada -
John Killmer,
Lead Independent Director -
Alfred Ingulli,
Independent Director -
Morton Erlich,
Independent Director -
Lawrence Clark,
Independent Director -
M. Esmail Zirakparvar,
Independent Director -
Scott Baskin,
Independent Director -
Debra Edwards,
Independent Director -
Emer Gunter,
Independent Director -
William Kuser,
Director of Investor Relations -
James Thompson,
Director of Bus. Devel., Portfolio Management Biologicals & Non-Crop -
Robert F. Gilbane,
Pres of Gemchem Inc -
Smith Cindy Baker,
See Remarks -
Jong Ad De,
MD AMVAC Netherlands BV -
John Rizzi,
VP Operations (AMVAC) -
Anne Turnbough,
See Remarks -
Steven D Macicek,
-
Suneet Ranganath,
See Remarks -
Peter Porpiglia,
See Remarks -
Jean Pougnier,
VP Business Dev. & Marketing -
Brett R Meinsen,
VICE PRESIDENT -
Mark H Blincoe,
VP/Chief Adm. Officer -
Jay R Harris,
Director -
Carl R Soderlind,
Director -
Keith M Cruiser Capital Adv...,
-
James Lehman,
Vice Pres of Sales Amvac Chem -
Glen D Johnson,
Sr.VP AMVAC Chem. Corp. -
Jerome L Coben,
Director -
Irving J Thau,
Director -
Herbert A Kraft,
Director -
Glenn A Wintemute,
Director -
Trevor Thorley,
COO & EVP of Amvac Chemical -
James A Barry,
Sr. VP, CFO & Sec/Trsr -
Robert F Gilbane,
President of GemChem, Inc. -
Christopher Hildreth,
Sr. VP of AMVAC Chemical Corp. -
John B Miles,
Director -
Doug Ashmore,
VICE PRESIDENT MFG- AMVAC -
Johann Venter,
See Remarks -
Patrick E Gottschalk,
-
Marisol Angelini,
-
Shayne M Wetherall,
CEO, AMGUARD -
Andrew B Naughton,
V.P., Director of Technology -
Keith M Rosenbloom,
-
Mark R Bassett,
-
John Mason Bennett,
VP US Crop Sales